Showing results (41-50 of 381) with videos related to
Sort By:
Pageof 39
The Journal of Antimicrobial Chemotherapy|April 10, 2004
Treatment choices for people infected with HCVSilvia Fargion, Anna Ludovica Fracanzani, Luca ValentiFrontiers in Neurology|July 19, 2021
Clinical Determinants of Disease Progression in Patients With Beta-Sarcoglycan Gene MutationsGiulia Bruna Marchetti, Luca Valenti, Yvan TorrenteCurrent Pharmaceutical Design|February 12, 2013
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatmentPaola Dongiovanni, Quentin M Anstee, Luca ValentiAtherosclerosis|February 8, 2019
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gapsRaul D Santos, Luca Valenti, Stefano RomeoNature Metabolism|October 17, 2025
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolismRosellina M Mancina, Luca Valenti, Stefano RomeoHepatology International|July 24, 2015
IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity?Luca Valenti, Edoardo Pulixi, Susanna La SpinaSeminars in Immunopathology|May 15, 2009
The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?Luca Valenti, Anna Ludovica Fracanzani, Silvia FargionUnited European Gastroenterology Journal|December 23, 2023
Predictors of controlled attenuation parameter in metabolic dysfunctionCristiana Bianco, Serena Pelusi, Sara Margarita, et al.Blood Cells, Molecules & Diseases|September 25, 2007
Erythroid differentiation and maturation from peripheral CD34+ cells in liquid culture: cellular and molecular characterizationLuisa Ronzoni, Paola Bonara, Daniela Rusconi, et al.JHEP Reports : Innovation in Hepatology|May 24, 2021
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targetsCristiana Bianco, Elia Casirati, Francesco Malvestiti, et al.Pageof 39